Clinical Trial

DIVision of the Interlobar Fissure in Patients Who Do Not Respond to Endobronchial Lung Volume Reduction

Study acronym: DIVIDE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Surgical division of fissure is hypothesized to be safe and feasible. However, there is no preparatory study to test this hypothesis. It is logically expected that morbidity from the procedure could be less than standard LVRS and in preparation to a side-to-side trial of fissure division versus standard LVRS, a safety and feasibility study is required to test this hypothesis and inform future trial design.
Trial Details
NCT Number NCT07682168
Lead Sponsor Rocco Bilancia
Conditions Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Lung Volume Reduction Surgery
Enrollment 15 participants
Start Date 2026-08
Primary Completion 2027-08 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-02